Description
An Hsp90 inhibitor (IC50 = 30 nM in a fluorescence polarization assay); selective for Hsp90 over a panel of kinases (IC50s = >20 µM); inhibits the proliferation of HCT116, SK-BR-3, LNCaP, DU145, and H157 cancer cells (IC50s = 0.28, 0.37, 0.17, 0.29, and 0.23 µM, respectively); induces degradation of HER2 and the androgen receptor in SK-BR-3 and LNCaP cells, respectively (IC50 = 0.33 µM for both)
Formal name: 4-chloro-6-[5-[[2-(4-morpholinyl)ethyl]amino]-1,2-benzisoxazol-3-yl]-1,3-benzenediol
Synonyms: BHI
Molecular weight: 389.8
CAS: 1012788-65-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Heat Shock Proteins||Research Area|Cancer||Research Area|Cell Biology|Cellular Chaperones